Product
CUROSURF
1 clinical trial
1 indication
Indication
Acute Respiratory Distress SyndromeClinical trial
Multicenter, Open-label, Randomised Trial to Assess the Efficacy and Tolerability of Poractant Alfa(Porcine Surfactant, Curosurf®) in Hospitalized Patients With SARS-COV-19 Acute Respiratory Distress Syndrome (ARDS)Status: Terminated, Estimated PCD: 2022-03-17